A Phase 1, Open-Label, Sequential Design Study to Evaluate the Potential Effect of Multiple Oral Doses of Extended-Release Combination of Naltrexone and Bupropion on the Pharmacokinetics of a Single Oral Dose of Metformin in Healthy Subjects

Trial Profile

A Phase 1, Open-Label, Sequential Design Study to Evaluate the Potential Effect of Multiple Oral Doses of Extended-Release Combination of Naltrexone and Bupropion on the Pharmacokinetics of a Single Oral Dose of Metformin in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Oct 2016

At a glance

  • Drugs Naltrexone/bupropion (Primary) ; Metformin
  • Indications Obesity
  • Focus Pharmacokinetics
  • Sponsors Orexigen Therapeutics; Takeda
  • Most Recent Events

    • 27 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 28 Apr 2016 Status changed from not yet recruiting to active, no longer recruiting.
    • 22 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top